Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Gacci M, Corona G, Salvi M et al (2012) A systematic review and meta-analysis on the use of Phosphodiesterase 5 inhibitors alone or in combination with a-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61: 994–1003
Inder WJ, Castle D (2011) Antipsychotic-induced hyperprolactinaemia. Aust N Z J Psychiatry; 45: 830–837
Malik P, Kemmler G, Hummer M et al; and the EUFEST Study Group (2011) Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol 31: 274–280
Melnik T, Althof S, Atallah AN et al (2011) Psychosocial interventions for premature ejaculation.Cochrane Database Syst Rev 8: CD008195
Moll JL, Brown CS (2011) The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature. J Sex Med 8: 956–970
Müller MJ (2011) Sexuelle Funktionsstörungen - Wenn Psychopharmaka das Liebesleben lähmen. NeuroTransmitter 2: 52–59
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benkert, O., Hippius, H. (2013). Medikamente zur Behandlung von sexuellen Störungen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-29810-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29809-7
Online ISBN: 978-3-642-29810-3
eBook Packages: Medicine (German Language)